Page last updated: 2024-08-21

thiazoles and Thromboembolism

thiazoles has been researched along with Thromboembolism in 78 studies

Research

Studies (78)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.28)	18.7374
1990's	1 (1.28)	18.2507
2000's	3 (3.85)	29.6817
2010's	56 (71.79)	24.3611
2020's	17 (21.79)	2.80

Authors

Authors	Studies
Chen, C; Colonna, P; Jin, J; Santamaria, A; Saxena, M; Unverdorben, M; Vanassche, T; von Heymann, C; Wilkins, R	1
Ahn, JM; Jung, SC; Kang, DY; Kang, JW; Kang, SH; Kao, HL; Kim, B; Kim, DH; Kim, KW; Kim, WJ; Ko, E; Ko, TY; Koo, HJ; Lam, CCS; Lee, JH; Lee, SA; Lee, YT; Lin, MS; Park, DW; Park, H; Park, SJ; Wei, J; Wong, YTA; Yang, DH; Yin, WH; Yun, SC	1
Kimura, T; Matsumoto, T; Mukai, Y; Okumura, K; Origasa, H; Takahashi, N; Yamaguchi, K	1
Antman, EM; Corbalan, R; Duris, T; Giugliano, RP; Juul-Möller, S; Kerschnitzki, M; Nicolau, AM; Nicolau, JC; Nordio, F; Ruff, CT; Trevisan, M; Voitk, J; Zierhut, W	1
Jimi, S; Kamei, T; Oohata, Y; Takahata, S; Tamura, T	1
Al-Saady, N; Cohen, A; Goette, A; Goudev, A; Hjortshøj, SP; Huber, K; Jin, J; Kozieł, M; Lip, GYH; Melino, M; Winters, SM	1
Aimo, A; De Caterina, R; Petricciuolo, S	1
Attena, E; De Caterina, R; Di Pasquale, G; Diemberger, I; Riva, L; Sangiuolo, R	1
Hirao, K; Hirao, T; Nakamura, RA; Oda, A; Okishige, K; Sasano, T; Shigeta, T; Tachibana, S; Yamauchi, Y; Yoshida, H	1
De Caterina, R; Goette, A; Heidbuchel, H; Huber, K; Jin, J; Lip, GYH; Merino, JL	1
Chen, C; Colonna, P; Laeis, P; Santamaria, A; Saxena, M; Unverdorben, M; Vanassche, T; von Heymann, C; Wilkins, R; Wolpert, D	1
Boriani, G; Corsini, A; Ferri, N; Proietti, M	1
Ameri, P; De Caterina, R; Di Pasquale, G; Riva, L; Toma, M	1
Doyama, H; Fujishiro, M; Fujita, T; Hasatani, K; Hatta, W; Hiasa, Y; Hikichi, T; Igarashi, K; Iguchi, M; Inoue, T; Kawaguchi, K; Kitamura, K; Kuribayashi, S; Mikami, T; Morita, Y; Nishida, T; Nishikawa, J; Oda, I; Sumiyama, K; Sumiyoshi, T; Tomida, H; Tsuji, Y; Uraoka, T; Yada, T; Yamamoto, K; Yanagitani, A; Yoshio, T	1
Goya, M; Hirao, K; Kawabata, M; Maeda, S; Sasano, T; Takahashi, Y; Yagishita, A	1
Chen, C; Colonna, P; Jin, J; Laeis, P; Santamaria, A; Saxena, M; Unverdorben, M; Vanassche, T; von Heymann, C; Wilkins, R	1
Jensen, M; Lip, GY; Nielsen, PB; Ording, AG; Søgaard, M	1
Antman, EM; Berg, DD; Braunwald, E; Giugliano, RP; Im, K; Jarolim, P; Morrow, DA; Ruff, CT; Rutman, H; Tang, M	1
Anderson, R; Baber, U; Boersma, E; Capranzano, P; Chen, C; Dangas, GD; Duggal, A; Hambrecht, R; Hayashida, K; Hengstenberg, C; Jin, J; Kim, HS; Laeis, P; Lang, I; Lanz, H; López-Otero, D; Mehran, R; Meincke, F; Möllmann, H; Moreno, R; Nombela-Franco, L; Nordbeck, P; Ohlmann, P; Pilgrim, T; Rodés-Cabau, J; Saito, S; Shawl, F; Thiele, H; Unverdorben, M; Valgimigli, M; Van Mieghem, NM; Veltkamp, R; Vranckx, P; Watanabe, Y; Yamamoto, M; Zamorano, JL	1
Di Pasquale, G; Riva, L	2
Barbera, V; Bellasi, A; Campana, C; Cozzolino, M; De Pascalis, A; Di Iorio, B; Di Lullo, L; Galliani, M; Ronco, C; Russo, D; Russo, L; Santoboni, F; Vitaliano, E	1
Goette, A; Hammwöhner, M	1
Kroeger, K; Kujath, P	1
Al-Saady, N; Banach, M; Ezekowitz, MD; Goette, A; Lip, GYH	1
Antman, EM; Braunwald, E; Cavallari, I; Deenadayalu, N; Giugliano, RP; Lanz, H; Mercuri, MF; Nordio, F; Ruff, CT; Rutman, H; Shi, M	1
Hanada, K; Matsubara, H; Matsumoto, SI; Shibata, S; Takahashi, H; Tsukimura, Y	1
Beyer-Westendorf, I; Beyer-Westendorf, J; Endig, S; Marten, S; Reitter, A; Tittl, L	1
Dülgeroglu, J; Schmidt, D	1
Márk, L	1
Mohebbi, N	1
Aizawa, Y; Fujita, S; Fuse, K; Ikeda, Y; Kitazawa, H; Okabe, M; Sato, T; Takahashi, M	1
Baber, U; Boersma, E; Chen, C; Dangas, GD; Hengstenberg, C; Mehran, R; Saito, S; Shi, M; Unverdorben, M; Valgimigli, M; Van Mieghem, NM; Veltkamp, R; Vranckx, P	1
Chang, SH; Chu, PH; Kuo, CF; Tseng, HJ; Wang, CL; Wen, MS; Wu, VC	1
Hu, A; Niu, J; Winkelmayer, WC	1
Jafari, M; MacKay, J; Stecker, EC; Warden, BA; Willman, A	1
Cohen, AA; De Caterina, R; Goette, A; Heidbuchel, H; Jin, J; Le Heuzey, JY; Lip, GYH; Melino, M; Merino, JL; Winters, SM	1
Ay, C; Beer, R; Haushofer, A; Kwasny, O; Leitgeb, J; Ortler, M; Schaden, E; Schöchl, H; Wiegele, M	1
Barrios, V; Cervantes, CE; Merino, JL	1
Chan, YH; Chang, SH; Chao, TF; Kuo, CT; Lee, HF; Lip, GYH; See, LC; Tu, HT; Wu, LS; Yeh, YH	1
Akiyoshi, K; Goya, M; Hirao, K; Kawabata, M; Koyama, T; Maeda, S; Sekigawa, M; Takahashi, Y; Yagishita, A; Yamamoto, T	1
Attena, E; D'Onofrio, A; Galasso, G; Mazzone, C; Melillo, E; Nigro, G; Parisi, V; Rago, A; Riegler, L; Rotunno, R; Russo, V	1
Honda, Y; Kamisato, C; Morishima, Y; Shibano, T	1
Majeed, A; Schulman, S	1
Schulman, S	1
Abe, K; Fuji, T; Fujita, S; Kawai, Y; Kimura, T; Kiuchi, Y; Nakamura, M; Tachibana, S	1
Dempfle, CE	1
Cowell, RP	1
Abe, K; Fuji, T; Fujita, S; Ibusuki, K; Kawai, Y; Kimura, T; Nakamura, M; Tachibana, S; Ushida, H; Wang, CJ	1
Ageno, W; Beyer-Westendorf, J	1
Oberhofer, E	1
Hogg, K; Weitz, JI; Yeh, CH	1
Al-Saadi, N; Ellenbogen, K; Ezekowitz, M; Goette, A; Jin, J; Lanz, H; Lip, GY; Mercuri, M; Merino, J; Zamoryakhin, D	1
Crawford, B; Morimoto, T; Ueda, S; Wada, K	1
Riess, H	1
Dzeshka, MS; Lip, GY	1
Cutler, NR; Goldenberg, NA; Halperin, JL; Hiatt, WR; Kessler, CM; Kittelson, JM; Schulman, S; Spyropoulos, AC; Steg, PG; Turpie, AG	1
Asahara, T; Izumi, M; Izumi, Y; Jiuchi, Y; Kozuru, H; Kumagai, K; Mawatari, M; Migita, K; Motokawa, S; Osaki, M; Sakai, T; Shirakawa, A	1
Al-Saady, N; Batushkin, V; de Groot, JR; Ezekowitz, MD; Fernandez, V; Goette, A; Grosso, MA; Jin, J; Kushnir, M; Lip, GY; Melino, M; Mercuri, MF; Merino, JL; Merkely, B; Pelekh, N; Spinar, J; Zamoryakhin, D; Zenin, S	1
Aspromonte, N; Colivicchi, F	1
Blann, AD; Boriani, G; Lip, GY	1
Buerke, M; Hoffmeister, HM	1
Antman, EM; Braunwald, E; Crompton, AE; Giugliano, RP; Huikuri, H; Lanz, H; Link, MS; Mercuri, MF; Murphy, SA; Oto, A; Ruff, CT; Scirica, BM	1
Broscaru, L; Gulba, DC	1
Antman, E; Carnicelli, AP; De Caterina, R; Giugliano, RP; Halperin, JL; Mercuri, MF; Nordio, F; Renda, G; Ruff, CT; Trevisan, M	1
Lopes, RD; Mahaffey, KW; Piccini, JP	1
Eikelboom, JW; Eriksson, BI; Quinlan, DJ	1
Gras, J	1
Douketis, JD; Gerotziafas, G; Kaatz, S; Ortel, TL; Schulman, S; Spyropoulos, AC	1
Brenner, B; Hoffman, R	1
Valle Bernad, R	1
Bottorff, MB; Gandhi, PK; Gentry, WM	1
Heeley, E; Hughes, K; Layton, D; Shakir, SA	1
Harris, S; Hughes, K; Layton, D; Shakir, SA	1
Lanes, S; Singh, G; Triadafilopoulos, G	1
Annis, KA; Balogoyen, DP; Mendoza, AR; Nishizawa, EE; Rynbrandt, RH	1
Morreale, AP; Plowman, BK	1

Reviews

26 review(s) available for thiazoles and Thromboembolism

Article	Year
[Oral anticoagulation in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease]. Giornale italiano di cardiologia (2006), 2020, Volume: 21, Issue:1 Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Diabetes Complications; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged; Off-Label Use; Prevalence; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency, Chronic; Risk Factors; Rivaroxaban; Sex Factors; Sleep Apnea, Obstructive; Stroke; Thiazoles; Thromboembolism	2020
Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice. Drugs, 2020, Volume: 80, Issue:11 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Factor Xa Inhibitors; Medication Therapy Management; Pyridines; Thiazoles; Thromboembolism	2020
[New oral anticoagulants in patients with atrial fibrillation: efficacy and safety data from the real world]. Giornale italiano di cardiologia (2006), 2017, Volume: 18, Issue:3 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Pyrazoles; Pyridines; Pyridones; Registries; Rivaroxaban; Thiazoles; Thromboembolism; Treatment Outcome	2017
Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation. Thrombosis research, 2017, Volume: 155 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Prospective Studies; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency, Chronic; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Warfarin	2017
The safety of edoxaban for treating atrial fibrillation. Expert opinion on drug safety, 2017, Volume: 16, Issue:11 Topics: Administration, Oral; Animals; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Medication Adherence; Pyridines; Stroke; Thiazoles; Thromboembolism	2017
[Peri-Interventional Management of Direct Oral Anticoagulants - Balancing Benefits and Risks]. Praxis, 2018, Volume: 107, Issue:9-10 Topics: Administration, Oral; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Atrial Fibrillation; Blood Coagulation Factors; Blood Coagulation Tests; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Male; Premedication; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Thromboembolism	2018
[The Multimorbid Patient: Use of New Oral Anticoagulants in Patients with Chronic Kidney Disease]. Praxis, 2018, Volume: 107, Issue:13 Topics: Anticoagulants; Arterial Occlusive Diseases; Atrial Fibrillation; Comorbidity; Contraindications; Coronary Disease; Dabigatran; Glomerular Filtration Rate; Kidney Failure, Chronic; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thromboembolism; Vitamin K	2018
Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation. Seminars in nephrology, 2018, Volume: 38, Issue:6 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Kidney Failure, Chronic; Pyrazoles; Pyridines; Pyridones; Renal Dialysis; Rivaroxaban; Thiazoles; Thromboembolism; Warfarin	2018
Use of Direct Oral Anticoagulants Among Patients Undergoing Cardioversion: The Importance of Timing Before Cardioversion. Journal of the American Heart Association, 2018, 11-20, Volume: 7, Issue:22 Topics: Administration, Oral; Anticoagulants; Dabigatran; Electric Countershock; Humans; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Thiazoles; Thromboembolism; Time Factors	2018
Edoxaban for the prevention of stroke in patients with atrial fibrillation. Expert review of cardiovascular therapy, 2019, Volume: 17, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Clinical Trials as Topic; Cost-Benefit Analysis; Factor Xa Inhibitors; Hemorrhage; Humans; Pyridines; Stroke; Thiazoles; Thromboembolism; Warfarin	2019
Bleeding and antidotes in new oral anticoagulants. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Drug Administration Schedule; Hemorrhage; Hemostatics; Humans; Morpholines; Prothrombin; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism	2013
Advantages and limitations of the new anticoagulants. Journal of internal medicine, 2014, Volume: 275, Issue:1 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Disease Management; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Factor Xa Inhibitors; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism	2014
Direct oral anticoagulants: integration into clinical practice. Postgraduate medical journal, 2014, Volume: 90, Issue:1067 Topics: Acute Kidney Injury; Administration, Oral; Anticoagulants; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Hemorrhage; Humans; Medication Adherence; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Treatment Outcome	2014
Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism. Thrombosis and haemostasis, 2015, Volume: 113, Issue:2 Topics: Administration, Oral; Anticoagulants; Blood Coagulation; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Female; Hemorrhage; Heparin; Humans; Male; Orthopedic Procedures; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Thromboembolism; Treatment Outcome; Venous Thromboembolism; Vitamin K	2015
Overview of the new oral anticoagulants: opportunities and challenges. Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:5 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Sensitivity and Specificity; Stroke; Thiazoles; Thiophenes; Thromboembolism; Warfarin	2015
Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies. Journal of cardiology, 2015, Volume: 66, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Azetidines; Benzylamines; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Odds Ratio; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Vitamin K	2015
[Treatment of bleeding complications due to oral anticoagulant drugs]. Laryngo- rhino- otologie, 2015, Volume: 94, Issue:10 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thromboembolism; Vitamin K	2015
Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:17 Topics: Atrial Fibrillation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Embolism; Factor Xa Inhibitors; Humans; Pyridines; Risk; Stroke; Thiazoles; Thromboembolism; Vitamin K; Warfarin	2015
Clinical relevance of pharmacokinetic and pharmacodynamic properties of edoxaban when treating patients with atrial fibrillation and heart failure. Expert opinion on drug metabolism & toxicology, 2017, Volume: 13, Issue:1 Topics: Administration, Oral; Aged; Atrial Fibrillation; Factor Xa Inhibitors; Heart Failure; Humans; Pyridines; Risk Factors; Stroke; Thiazoles; Thromboembolism	2017
[Management of NOAK administration during invasive or surgical interventions : When and how to pause and when to restart?] Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:2 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Loss, Surgical; Dabigatran; Drug Interactions; Half-Life; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiazoles; Thromboembolism; Vitamin K	2017
Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation. Current opinion in cardiology, 2010, Volume: 25, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Benzamides; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism; Warfarin	2010
Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism. Annual review of medicine, 2011, Volume: 62 Topics: Acute Coronary Syndrome; Amidines; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombin; Thromboembolism; Treatment Outcome; Vitamin K	2011
[Thromboembolic prophylaxis 2011: is warfarin on the wane?]. Giornale italiano di cardiologia (2006), 2011, Volume: 12, Issue:9 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzamides; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Evidence-Based Medicine; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism; Treatment Outcome; Warfarin	2011
Edoxaban for the prevention of thromboembolic events after surgery. Drugs of today (Barcelona, Spain : 1998), 2011, Volume: 47, Issue:10 Topics: Animals; Clinical Trials as Topic; Factor Xa Inhibitors; Humans; Postoperative Complications; Pyridines; Thiazoles; Thromboembolism	2011
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:4 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Elective Surgical Procedures; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Ischemic Attack, Transient; Medical Records; Morpholines; Perioperative Period; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism	2012
The promise of novel direct oral anticoagulants. Best practice & research. Clinical haematology, 2012, Volume: 25, Issue:3 Topics: Anticoagulants; Antithrombins; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Thromboembolism; Warfarin	2012

Trials

20 trial(s) available for thiazoles and Thromboembolism

Article	Year
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial. Circulation, 2022, 08-09, Volume: 146, Issue:6 Topics: Anticoagulants; Aortic Valve; Aortic Valve Stenosis; Humans; Platelet Aggregation Inhibitors; Pyridines; Risk Factors; Thiazoles; Thromboembolism; Thrombosis; Transcatheter Aortic Valve Replacement; Treatment Outcome	2022
Efficacy and Safety of Uninterrupted Periprocedural Edoxaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation　- The Prospective KYU-RABLE Study. Circulation journal : official journal of the Japanese Circulation Society, 2019, 09-25, Volume: 83, Issue:10 Topics: Administration, Oral; Aged; Atrial Fibrillation; Blood Coagulation; Catheter Ablation; Drug Administration Schedule; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Prospective Studies; Pyridines; Risk Factors; Thiazoles; Thromboembolism; Time Factors; Treatment Outcome	2019
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial. Clinical research in cardiology : official journal of the German Cardiac Society, 2020, Volume: 109, Issue:8 Topics: Aged; Anticoagulants; Atrial Fibrillation; Electric Countershock; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Pyridines; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin	2020
[ETNA-AF study: Italian baseline data and comparison with the European population in atrial fibrillation patients treated with edoxaban]. Giornale italiano di cardiologia (2006), 2020, Volume: 21, Issue:2 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Europe; Factor Xa Inhibitors; Female; Humans; Italy; Male; Middle Aged; Pyridines; Registries; Thiazoles; Thromboembolism	2020
Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial. Clinical research in cardiology : official journal of the German Cardiac Society, 2020, Volume: 109, Issue:11 Topics: Aged; Atrial Fibrillation; Electric Countershock; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyridines; Thiazoles; Thromboembolism; Time Factors; Treatment Outcome; Warfarin	2020
[One-year follow-up of Italian patients with atrial fibrillation treated with edoxaban in ETNA-AF Europe]. Giornale italiano di cardiologia (2006), 2020, Volume: 21, Issue:7 Topics: Age Factors; Aged; Aged, 80 and over; Atrial Fibrillation; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Humans; Italy; Male; Medication Adherence; Middle Aged; Prospective Studies; Pyridines; Stroke; Thiazoles; Thromboembolism	2020
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. The New England journal of medicine, 2021, 12-02, Volume: 385, Issue:23 Topics: 4-Hydroxycoumarins; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Mortality; Phenindione; Postoperative Complications; Pyridines; Thiazoles; Thromboembolism; Transcatheter Aortic Valve Replacement; Vitamin K	2021
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. American heart journal, 2017, Volume: 193 Topics: Aged; Anticoagulants; Atrial Fibrillation; Creatinine; Dose-Response Relationship, Drug; Electric Countershock; Factor Xa Inhibitors; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Pyridines; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin	2017
Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial. International journal of cardiology, 2018, 04-15, Volume: 257 Topics: Aged; Anticoagulants; Atrial Fibrillation; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pyridines; Retrospective Studies; Risk Factors; Stroke; Thiazoles; Thromboembolism; Warfarin; Withholding Treatment	2018
Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119). International journal of cardiology, 2018, 07-01, Volume: 262 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Body Mass Index; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Obesity; Prospective Studies; Pyrazoles; Pyridines; Pyridones; Registries; Rivaroxaban; Thiazoles; Thromboembolism; Treatment Outcome; Vitamin K	2018
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial. American heart journal, 2018, Volume: 205 Topics: Aortic Valve; Aortic Valve Stenosis; Atrial Fibrillation; Factor Xa Inhibitors; Humans; Prospective Studies; Pyridines; Standard of Care; Thiazoles; Thromboembolism; Thrombolytic Therapy; Transcatheter Aortic Valve Replacement; Treatment Outcome	2018
Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial. American heart journal, 2019, Volume: 209 Topics: Anticoagulants; Atrial Fibrillation; Dose-Response Relationship, Drug; Electric Countershock; Factor Xa Inhibitors; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Pyridines; Remission, Spontaneous; Retrospective Studies; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin	2019
Safety and efficacy of edoxaban in patients undergoing hip fracture surgery. Thrombosis research, 2014, Volume: 133, Issue:6 Topics: Aged; Blood Loss, Surgical; Drug Administration Schedule; Enoxaparin; Factor Xa Inhibitors; Female; Hip Fractures; Humans; Injections, Subcutaneous; Male; Pyridines; Thiazoles; Thromboembolism	2014
Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial. Thrombosis research, 2014, Volume: 134, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage; Pyridines; Risk Assessment; Thiazoles; Thromboembolism; Treatment Outcome	2014
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. American heart journal, 2015, Volume: 169, Issue:5 Topics: Adult; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Electric Countershock; Factor Xa Inhibitors; Female; Humans; Male; Prospective Studies; Pyridines; Research Design; Stroke; Thiazoles; Thromboembolism; Warfarin	2015
Reduced induction of anti-PF4/heparin antibody in RA patients after total knee arthroplasty. Arthritis research & therapy, 2016, 08-25, Volume: 18 Topics: Aged; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Autoantibodies; Autoantigens; Enzyme-Linked Immunosorbent Assay; Factor Xa Inhibitors; Female; Humans; Immunoblotting; Immunoglobulin G; Male; Middle Aged; Osteoarthritis; Platelet Factor 4; Pyridines; Seroconversion; Thiazoles; Thrombocytopenia; Thromboembolism	2016
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. Lancet (London, England), 2016, Oct-22, Volume: 388, Issue:10055 Topics: Aged; Anticoagulants; Atrial Fibrillation; Electric Countershock; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; Middle Aged; Prospective Studies; Pyridines; Stroke; Thiazoles; Thromboembolism; Warfarin	2016
Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circulation. Arrhythmia and electrophysiology, 2017, Volume: 10, Issue:1 Topics: Aged; Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Pyridines; Risk Factors; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin	2017
Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves. Circulation, 2017, 03-28, Volume: 135, Issue:13 Topics: Anticoagulants; Atrial Fibrillation; Bioprosthesis; Blood Coagulation; Factor Xa Inhibitors; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Pyridines; Risk Factors; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin	2017
Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam. The American journal of medicine, 2004, Jul-15, Volume: 117, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular System; Diclofenac; Dose-Response Relationship, Drug; Europe; Female; Gastrointestinal Diseases; Humans; Male; Meloxicam; Middle Aged; Naproxen; North America; Piroxicam; Risk Factors; Severity of Illness Index; Thiazines; Thiazoles; Thromboembolism; Time Factors; Treatment Failure; Upper Gastrointestinal Tract	2004

Other Studies

32 other study(ies) available for thiazoles and Thromboembolism

Article	Year
Thromboembolic and bleeding risks in edoxaban patients with pacemaker and cardiac monitoring procedures: Outcomes of the Global EMIT program. Pacing and clinical electrophysiology : PACE, 2022, Volume: 45, Issue:1 Topics: Aged; Anticoagulants; Cardiac Resynchronization Therapy Devices; Europe; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Ischemia; Male; Pacemaker, Artificial; Prospective Studies; Pyridines; Republic of Korea; Risk Factors; Taiwan; Thiazoles; Thromboembolism	2022
Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. European heart journal. Cardiovascular pharmacotherapy, 2020, 07-01, Volume: 6, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Comorbidity; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Thiazoles; Thromboembolism; Time Factors; Treatment Outcome; Warfarin	2020
[Successful Management of Deep Vein Thromboembolism and Pulmonary Embolism by Edoxaban for Long-Term 5-FU-Based Chemotherapy for Colon Cancer-A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:12 Topics: Aged; Anticoagulants; Colonic Neoplasms; Fluorouracil; Humans; Pulmonary Embolism; Pyridines; Thiazoles; Thromboembolism; Venous Thromboembolism	2019
Blood Coagulation Status during Cryofreezing Ablation and Effects of the Direct Anticoagulants Dabigatran and Edoxaban. International heart journal, 2020, Mar-28, Volume: 61, Issue:2 Topics: Aged; Antithrombins; Cryosurgery; Dabigatran; Female; Humans; Male; Middle Aged; Pyridines; Thiazoles; Thromboembolism	2020
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT-AF/VTE study. Clinical cardiology, 2020, Volume: 43, Issue:7 Topics: Adult; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Perioperative Period; Prospective Studies; Pyridines; Thiazoles; Thromboembolism; Treatment Outcome	2020
Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021, Volume: 24, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Endoscopic Mucosal Resection; Female; Humans; Japan; Male; Middle Aged; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stomach; Stomach Neoplasms; Thiazoles; Thromboembolism; Warfarin	2021
A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation. International heart journal, 2020, Sep-29, Volume: 61, Issue:5 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Loss, Surgical; Carotid Artery Diseases; Cerebral Infarction; Dabigatran; Digestive System Surgical Procedures; Elective Surgical Procedures; Embolism; Endoscopy; Factor Xa Inhibitors; Female; Humans; Male; Myocardial Infarction; Orthopedic Procedures; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thromboembolism; Urologic Surgical Procedures; Vascular Surgical Procedures	2020
Elderly patients with atrial fibrillation in routine clinical practice-peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, ob BMC cardiovascular disorders, 2020, 12-01, Volume: 20, Issue:1 Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Asia; Atrial Fibrillation; Cerebrovascular Disorders; Drug Administration Schedule; Europe; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Perioperative Care; Postoperative Hemorrhage; Prospective Studies; Pyridines; Registries; Risk Assessment; Risk Factors; Thiazoles; Thromboembolism; Treatment Outcome	2020
Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study. International journal of stroke : official journal of the International Stroke Society, 2022, Volume: 17, Issue:5 Topics: Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Pyridines; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin	2022
A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48. Journal of the American College of Cardiology, 2021, 08-10, Volume: 78, Issue:6 Topics: Atrial Fibrillation; Biomarkers; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Proteomics; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Thiazoles; Thromboembolism	2021
[Antiembolic Stockings - Great Effects in Edoxaban Approval Studies]. Zentralblatt fur Chirurgie, 2017, Volume: 142, Issue:5 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Combined Modality Therapy; Drug Approval; Evidence-Based Medicine; Germany; Guideline Adherence; Postoperative Complications; Pyridines; Stockings, Compression; Thiazoles; Thromboembolism; Venous Thrombosis	2017
A quantitative LC/MSMS method for determination of edoxaban, a Xa inhibitor and its pharmacokinetic application in patients after total knee arthroplasty. Biomedical chromatography : BMC, 2018, Volume: 32, Issue:6 Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Chromatography, Liquid; Factor Xa Inhibitors; Female; Humans; Linear Models; Male; Postoperative Complications; Pyridines; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles; Thromboembolism	2018
[Stroke prevention in the elderly: effectiveness and safety of edoxaban in elderly patients according to the results of the ENGAGE AF study]. Orvosi hetilap, 2018, Volume: 159, Issue:20 Topics: Aged; Anticoagulants; Factor Xa Inhibitors; Female; Humans; Hungary; Male; Patient Safety; Pyridines; Stroke; Thiazoles; Thromboembolism; Treatment Outcome	2018
The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:11 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Chi-Square Distribution; Dabigatran; Databases, Factual; Drug Dosage Calculations; Female; Hemorrhage; Humans; Inappropriate Prescribing; Incidence; Japan; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Prevalence; Pyrazoles; Pyridines; Pyridones; Registries; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Time Factors; Treatment Outcome	2018
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study. Journal of the American Heart Association, 2018, 08-07, Volume: 7, Issue:15 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hepatic Insufficiency; Humans; Male; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Warfarin	2018
Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement. Critical care (London, England), 2019, Feb-22, Volume: 23, Issue:1 Topics: Administration, Oral; Anticoagulants; Austria; Brain Injuries, Traumatic; Consensus; Dabigatran; Deamino Arginine Vasopressin; Humans; Interdisciplinary Communication; Partial Thromboplastin Time; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thromboembolism; Tomography, X-Ray Computed; Tranexamic Acid; Treatment Outcome; Vitamin K	2019
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation. Chest, 2019, Volume: 156, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Asian People; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Hemorrhage; Humans; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Taiwan; Thiazoles; Thromboembolism; Treatment Outcome; Warfarin	2019
Excessive Prolongation of Coagulation Time During Treatment With Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation. The Canadian journal of cardiology, 2019, Volume: 35, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Japan; Male; Prognosis; Pyridines; Retrospective Studies; Thiazoles; Thromboembolism	2019
Real-life Performance of Edoxaban in Elderly Patients With Atrial Fibrillation: a Multicenter Propensity Score-Matched Cohort Study. Clinical therapeutics, 2019, Volume: 41, Issue:8 Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Propensity Score; Pyridines; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Vitamin K	2019
Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats. Thrombosis research, 2013, Volume: 132, Issue:2 Topics: Animals; Anticoagulants; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Heparin; Hirudins; Male; Pyridines; Rats; Rats, Wistar; Recombinant Proteins; Thiazoles; Thromboembolism; Warfarin	2013
Direct oral anticoagulants--pharmacology, drug interactions, and side effects. Seminars in hematology, 2014, Volume: 51, Issue:2 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Drug Monitoring; Half-Life; Hemorrhage; Humans; Kidney; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism	2014
[New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing]. MMW Fortschritte der Medizin, 2015, Jan-19, Volume: 157, Issue:1 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Drug Substitution; Half-Life; Hemorrhage; Humans; Kidney Function Tests; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thromboembolism; Warfarin	2015
[IQWiG confirms significant additional applications for edoxaban ]. MMW Fortschritte der Medizin, 2015, Dec-14, Volume: 157, Issue:21-22 Topics: Adult; Anticoagulants; Atrial Fibrillation; Drug Approval; Germany; Humans; National Health Programs; Pulmonary Embolism; Pyridines; Stroke; Thiazoles; Thromboembolism; Venous Thrombosis	2015
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation. Thrombosis and haemostasis, 2016, 08-30, Volume: 116, Issue:3 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Hemorrhage; Humans; Models, Statistical; Pyridines; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles; Thromboembolism; Warfarin	2016
Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016, Volume: 18, Issue:10 Topics: Administration, Oral; Atrial Fibrillation; Cost Savings; Cost-Benefit Analysis; Drug Costs; Europe; Factor Xa Inhibitors; Forecasting; Humans; Models, Economic; Practice Patterns, Physicians'; Pyridines; Stroke; Thiazoles; Thromboembolism; Time Factors; Treatment Outcome; Warfarin	2016
[Non-vitamin K dependent oral anticoagulants : What is important in intensive care medicine]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Dabigatran; Electric Countershock; Emergency Service, Hospital; Factor Xa Inhibitors; Hemorrhage; Humans; Intensive Care Units; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombin; Thromboembolism; Vitamin K	2017
[Introduction]. Revista clinica espanola, 2012, Volume: 212 Suppl 1 Topics: Acenocoumarol; Anticoagulants; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism; Thrombosis; Warfarin	2012
Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system database. Seminars in arthritis and rheumatism, 2013, Volume: 42, Issue:6 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Child; Data Mining; Febuxostat; Female; Gout Suppressants; Humans; Male; Middle Aged; Thiazoles; Thromboembolism; United States; United States Food and Drug Administration	2013
Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data. Rheumatology (Oxford, England), 2003, Volume: 42, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Chi-Square Distribution; Cohort Studies; Cyclooxygenase Inhibitors; England; Family Practice; Female; Humans; Incidence; Lactones; Male; Meloxicam; Middle Aged; Osteoarthritis; Risk Factors; Sulfones; Survival Analysis; Thiazines; Thiazoles; Thromboembolism	2003
Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data. Rheumatology (Oxford, England), 2003, Volume: 42, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Celecoxib; Cerebrovascular Disorders; Chi-Square Distribution; Cohort Studies; Cyclooxygenase Inhibitors; England; Family Practice; Female; Humans; Incidence; Male; Meloxicam; Middle Aged; Osteoarthritis; Peripheral Vascular Diseases; Pyrazoles; Risk Factors; Sulfonamides; Survival Analysis; Thiazines; Thiazoles; Thromboembolism	2003
Synthesis and platelet aggregation inhibitory activity of 4,5-bis(aryl)-2-substituted-thiazoles. Journal of medicinal chemistry, 1981, Volume: 24, Issue:12 Topics: Animals; Chemical Phenomena; Chemistry; Guinea Pigs; Humans; In Vitro Techniques; Male; Platelet Aggregation; Thiazoles; Thromboembolism	1981
Possible troglitazone-warfarin interaction. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, May-15, Volume: 55, Issue:10 Topics: Anticoagulants; Blood Coagulation; Chromans; Diabetes Mellitus; Drug Interactions; Humans; Hypoglycemic Agents; International Normalized Ratio; Male; Middle Aged; Thiazoles; Thiazolidinediones; Thromboembolism; Troglitazone; Warfarin	1998